Soy and its isoflavones: The truth behind the science in breast cancer

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 8, 2013, Pages 1178-1187

  Douglas, Crystal C ^a   Johnson, Sarah A ^a   Arjmandi, Bahram H ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Estrogen metabolism; Isoflavones; Mammographic density; Menstrual cycle; Phytoestrogens; Tumors

Indexed keywords

DAIDZIN; EQUOL; ESTRADIOL; ESTROGEN; GENISTIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PROGESTERONE RECEPTOR; PROTEIN PS2; SOY ISOFLAVONE DERIVATIVE; SOYBEAN PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; DIETARY INTAKE; DRUG BIOAVAILABILITY; DRUG SAFETY; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; ESTROGEN RESPONSIVE ELEMENT; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; HUMAN; MENSTRUAL CYCLE; META ANALYSIS (TOPIC); NIPPLE ASPIRATION; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOYBEAN; SOYBEAN MILK;

ANIMALS; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; ESTROGENS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; ISOFLAVONES; NEOPLASMS, HORMONE-DEPENDENT; PHYTOESTROGENS; SOYBEANS;

EID: 84888267104     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/18715206113139990320     Document Type: Article

References (107)

1. GLOBOCAN Breast Cancer Incidence and Mortality Worldwide in 2008 Summary. http://globocan.iarc.fr/factsheets/cancers/breast.asp (Accessed June 11, 2012),
2. Ziegler, R.G., Hoover, R.N., Pike, M.C., Hildesheim, A., Nomura, A.M., West, D.W., Wu-Williams, A.H., Kolonel, L.N., Horn-Ross, P.L., Rosenthal, J.F., Hyer, M.B. Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst., 1993, 85, 1819-1827.
3. Stanford, J.L., Herrinton, L.J., Schwartz, S.M., Weiss, N.S. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology, 1995, 6, 181-183.
4. Lee, S.A., Shu, X.O., Li, H., Yang, G., Cai, H., Wen, W., Ji, B.T., Gao, J., Gao, Y.T., Zheng, W., Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am. J. Clin. Nutr., 2009, 89, 1920-1926.
5. Butler, L.M., Wu, A.H., Wang, R., Koh, W.P., Yuan, J.M., Yu, M.C. A vegetable-fruit-soy dietary pattern protects against breast cancer among postmenopausal Singapore Chinese women. Am. J. Clin. Nutr., 2010, 91, 1013-1019.
6. Trock, B.J., Hilakivi-Clarke, L., Clarke, R. Meta-analysis of soy intake and breast cancer risk. J. Natl. Cancer Inst., 2006, 98, 459-71.
7. Chun, O.K., Chung, S.J., Song, W.O. Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J. Am. Diet. Assoc., 2009, 109, 245-54.
8. Adlercreutz, H., Mazur, W. Phyto-oestrogens and Western diseases. Annals of medicine, 1997, 29, 95-120.
9. Messina, M., Nagata, C., Wu, A.H. Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer, 2006, 55, 1-12.
10. Reinli, K., Block, G. Phytoestrogen content of foods--a compendium of literature values. Nutr. Cancer, 1996, 26, 123-48.
11. Adlercreutz, H. Phytoestrogens: Epidemiology and a possible role in cancer protection. Environ. Health Perspect., 1995, 103 Suppl 7, 103-112.
12. Hwang, C.S., Kwak, H.S., Lim, H.J., Lee, S.H., Kang, Y.S., Choe, T.B., Hur, H.G., Han, K.O. Isoflavone metabolites and their in vitro dual functions: They can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J. Steroid Biochem. Mol. Biol., 2006, 101, 246-253.
13. Wood, C.E., Register, T.C., Franke, A.A., Anthony, M.S., Cline, J.M. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res., 2006, 66, 1241-1249.
14. Larkin, T., Price, W.E., Astheimer, L. The key importance of soy isoflavone bioavailability to understanding health benefits. Crit. Rev. Food Sci. Nutr., 2008, 48, 538-552.
15. Vitale, D. C., Piazza, C., Melilli, B., Drago, F., Salomone, S., Isoflavones: Estrogenic activity, biological effect and bioavailability. Eur. J. Drug Metab. Pharmacokinet., 2012.
16. Setchell, K.D., Brown, N.M., Desai, P.B., Zimmer-Nechimias, L., Wolfe, B., Jakate, A.S., Creutzinger, V., Heubi, J.E., Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr., 2003, 133, 1027-1035.
17. Chen, J., Lin, H., Hu, M. Metabolism of flavonoids via enteric recycling: role of intestinal disposition. J Pharmacol. Exp. Ther., 2003, 304, 1228-1235.
18. Xu, X., Harris, K.S., Wang, H.J., Murphy, P.A., Hendrich, S., Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr., 1995, 125, 2307-2315.
19. Franke, A. A., Custer, L. J., Wang, W., Shi, C. Y., HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc. Soc. Exp. Biol. Med., 1998, 217, 263-73.
20. Richelle, M., Pridmore-Merten, S., Bodenstab, S., Enslen, M., Offord, E. A. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J. Nutr., 2002, 132, 2587-92.
21. Parodi, P. The role of intestinal bacteria in the causation and prevention of cancer: modulation by diet and probiotics. Aust J Dairy Technol, 1999, 54, 103-121.
22. Kulkarni, K.H., Yang, Z., Niu, T., Hu, M., Effects of estrogen and estrus cycle on pharmacokinetics, absorption, and disposition of genistein in female Sprague-Dawley rats. J. Agric. Food Chem., 2012, 60, 7949-7956.
23. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., Gustafsson, J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology, 1997, 138, 863-870.
24. Pike, A.C., Brzozowski, A.M., Hubbard, R.E., Bonn, T., Thorsell, A.G., Engström, O., Ljunggren, J., Gustafsson, J.A., Carlquist, M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J., 1999, 18, 4608-4618.
25. Kostelac, D., Rechkemmer, G., Briviba, K. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J. Agric. Food Chem., 2003, 51, 7632-5.
26. Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., van der Saag, P.T., van der Burg, B., Gustafsson, J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 1998, 139, 4252-63.
27. Teede, H.J., Dalais, F.S., McGrath, B.P. Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am. J. Clin. Nutr., 2004, 79, 396-401.
28. Messina, M., McCaskill-Stevens, W., Lampe, J. W., Addressing the soy and breast cancer relationship: Review, commentary, and workshop proceedings. J. Natl. Cancer Inst., 2006, 98, 1275-1284.
29. Cassidy, A., Bingham, S., Setchell, K. D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 1994, 60, 333-340.
30. Lu, L.J., Anderson, K.E., Grady, J. J., Nagamani, M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol. Biomarkers Prev., 1996, 5, 63-70.
31. Extension, C.C. Estrogen and breast cancer risk: What is the relationship? Available at: http://envirocancer.cornell.edu/factsheet/General/fs9.estrogen.pdf (Accessed June 12, 2012),
32. Cederroth, C.R., Nef, S. Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol, 2009, 304, 30-42.
33. Centers for Disease Control and Prevention. Breast Cancer: Risk Factors. Available at: http://www.cdc.gov/cancer/breast/basic_info/risk_factors.htm (Accessed June 12, 2012)
34. Simpson, E.R. Sources of estrogen and their importance. J. Steroid Biochem. Mol. Biol., 2003, 86, 225-230.
35. Pasqualini, J. R., Chetrite, G., Blacker, C., Feinstein, M. C., Delalonde, L., Talbi, M., Maloche, C. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J. Clin. Endocrinol. Metab., 1996, 81, 1460-1464.
36. Bernstein, L., Yuan, J.M., Ross, R.K., Pike, M.C., Hanisch, R., Lobo, R., Stanczyk, F., Gao, Y.T., Henderson, B.E. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer casecontrol studies. Cancer Causes Control, 1990, 1, 51-58.
37. Dai, Q., Shu, X.O., Jin, F., Potter, J.D., Kushi, L.H., Teas, J., Gao, Y.T., Zheng, W. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br. J. Cancer, 2001, 85, 372-378.
38. Zhang, C., Ho, S. C., Lin, F., Cheng, S., Fu, J., Chen, Y. Soy product and isoflavone intake and breast cancer risk defined by hormone receptor status. Cancer Sci., 2010, 101, 501-7.
39. Wu, A.H., Yu, M.C., Tseng, C.C., Pike, M.C. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer, 2008, 98, 9-14.
40. Horn-Ross, P. L. Assessing phytoestrogen exposure via a foodfrequency questionnaire. Cancer Causes Control, 2001, 12, 477-478.
41. Horn-Ross, P.L., John, E.M., Lee, M., Stewart, S.L., Koo, J., Sakoda, L.C., Shiau, A.C., Goldstein, J., Davis, P., Perez-Stable, E.J. Phytoestrogen consumption and breast cancer risk in a multiethnic population: The Bay Area Breast Cancer Study. Am. J. Epidemiol., 2001, 154, 434-441.
42. Shu, X.O., Jin, F., Dai, Q., Wen, W., Potter, J.D., Kushi, L.H., Ruan, Z., Gao, Y.T., Zheng, W. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomarkers Prev., 2001, 10, 483-488.
43. Wu, A.H., Wan, P., Hankin, J., Tseng, C.C., Yu, M.C., Pike, M.C. Adolescent and adult soy intake and risk of breast cancer in Asian- Americans. Carcinogenesis, 2002, 23, 1491-1496.
44. Warri, A., Saarinen, N.M., Makela, S., Hilakivi-Clarke, L. The role of early life genistein exposures in modifying breast cancer risk. Br. J. Cancer, 2008, 98, 1485-1493.
45. Hilakivi-Clarke, L. Nutritional modulation of terminal end buds: Its relevance to breast cancer prevention. Curr. Cancer Drug Targets, 2007, 7, 465-74.
46. Russo, J., Hu, Y.F., Yang, X., Russo, I.H. Developmental, cellular, and molecular basis of human breast cancer. J. Natl. Cancer Inst. Monogr., 2000, 17-37.
47. Korde, L.A., Wu, A.H., Fears, T., Nomura, A. M., West, D.W., Kolonel, L.N., Pike, M.C., Hoover, R. N., Ziegler, R.G. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol. Biomarkers Prev., 2009, 18, 1050-1059.
48. Leung, W., Goldberg, F., Zee, B., Sterns, E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery, 1997, 122, 669-73; discussion 673-4.
49. Harvey, J.A., Bovbjerg, V.E. Quantitative assessment of mammographic breast density: Relationship with breast cancer risk. Radiology, 2004, 230, 29-41.
50. Jakes, R.W., Duffy, S.W., Ng, F.C., Gao, F., Ng, E.H., Seow, A., Lee, H.P., Yu, M.C. Mammographic parenchymal patterns and self-reported soy intake in Singapore Chinese women. Cancer Epidemiol. Biomarkers Prev., 2002, 11, 608-613.
51. Maskarinec, G., Takata, Y., Franke, A.A., Williams, A.E., Murphy, S.P. A 2-year soy intervention in premenopausal women does not change mammographic densities. J. Nutr., 2004, 134, 3089-94.
52. Palacios, S., Pornel, B., Vazquez, F., Aubert, L., Chantre, P., Mares, P. Long-term endometrial and breast safety of a specific, standardized soy extract. Climacteric, 2010, 13, 368-75.
53. Maskarinec, G., Williams, A.E., Carlin, L. Mammographic densities in a one-year isoflavone intervention. Eur. J. Cancer Prev., 2003, 12, 165-169.
54. Maskarinec, G., Verheus, M., Steinberg, F.M., Amato, P., Cramer, M.K., Lewis, R.D., Murray, M.J., Young, R.L., Wong, W.W. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J. Nutr., 2009, 139, 981-986.
55. Verheus, M., van Gils, C.H., Kreijkamp-Kaspers, S., Kok, L., Peeters, P.H., Grobbee, D.E., van der Schouw, Y.T. Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 2008, 17, 2632-2638.
56. Lu, L. J., Anderson, K. E., Grady, J. J., Kohen, F., Nagamani, M. Decreased ovarian hormones during a soya diet: Implications for breast cancer prevention. Cancer Res., 2000, 60, 4112-21.
57. Whitehead, S. A., Cross, J. E., Burden, C., Lacey, M. Acute and chronic effects of genistein, tyrphostin and lavendustin A on steroid synthesis in luteinized human granulosa cells. Hum. Reprod., 2002, 17, 589-94.
58. Rice, S., Mason, H. D., Whitehead, S. A. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J. Steroid Biochem. Mol. Biol., 2006, 101, 216-25.
59. The National Cancer Institute. Aromatase Inhibitors. Available at: http://www.cancer.gov/cancertopics/treatment/aromataseinhibitors/Page4 (Accessed May 21, 2012).
60. Ferguson, D.J., Anderson, T.J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the resting human breast. Br. J. Cancer, 1981, 44, 177-181.
61. Lenton, E.A., Lawrence, G.F., Coleman, R. A., Cooke, I.D. Individual variation in gonadotrophin and steroid concentrations and in the lengths of the follicular and luteal phases in women with regular menstrual cycles. Clin. Reprod. Fertil., 1983, 2, 143-150.
62. Olsson, H., Landin-Olsson, M., Gullberg, B. Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease. J. Natl. Cancer Inst., 1983, 70, 17-20.
63. Nagata, C., Takatsuka, N., Inaba, S., Kawakami, N., Shimizu, H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women. J. Natl. Cancer Inst., 1998, 90, 1830-1835.
64. Duncan, A.M., Merz, B. E., Xu, X., Nagel, T.C., Phipps, W.R., Kurzer, M.S. Soy isoflavones exert modest hormonal effects in premenopausal women. J. Clin. Endocrinol. Metab., 1999, 84, 192-197.
65. Cassidy, A., Bingham, S., Setchell, K., Biological effects of isoflavones in young women: Importance of the chemical composition of soyabean products. Br. J. Nutr., 1995, 74, 587-601.
66. Fuhrman, B.J., Pfeiffer, R., Xu, X., Wu, A.H., Korde, L., Gail, M.H., Keefer, L.K., Veenstra, T.D., Hoover, R.N., Ziegler, R.G. Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women. Cancer Epidemiol. Biomarkers Prev., 2009, 18, 2751-2760.
67. Morimoto, Y., Conroy, S.M., Pagano, I.S., Isaki, M., Franke, A.A., Nordt, F.J., Maskarinec, G. Urinary estrogen metabolites during a randomized soy trial. Nutr. Cancer, 2012, 64, 307-314.
68. Zhu, B.T., Conney, A.H., Functional role of estrogen metabolism in target cells: Review and perspectives. Carcinogenesis, 1998, 19, 1-27.
69. Yager, J.D., Liehr, J.G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 1996, 36, 203-232.
70. Bradlow, H.L., Telang, N.T., Sepkovic, D.W., Osborne, M.P. 2-hydroxyestrone: The 'good' estrogen. J. Endocrinol., 1996, 150 Suppl, S259-265.
71. Kabat, G.C., Chang, C.J., Sparano, J.A., Sepkovie, D.W., Hu, X.P., Khalil, A., Rosenblatt, R., Bradlow, H. L. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev., 1997, 6, 505-509.
72. Fishman, J., Osborne, M.P., Telang, N.T. The role of estrogen in mammary carcinogenesis. Ann. N Y Acad. Sci., 1995, 768, 91-100.
73. Im, A., Vogel, V.G., Ahrendt, G., Lloyd, S., Ragin, C., Garte, S., Taioli, E. Urinary estrogen metabolites in women at high risk for breast cancer. Carcinogenesis, 2009, 30, 1532-1535.
74. Xu, X., Duncan, A.M., Wangen, K.E., Kurzer, M.S. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 2000, 9, 781-786.
75. Xu, X., Duncan, A.M., Merz, B.E., Kurzer, M.S. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol. Biomarkers Prev., 1998, 7, 1101-1108.
76. Muti, P., Bradlow, H.L., Micheli, A., Krogh, V., Freudenheim, J.L., Schunemann, H.J., Stanulla, M., Yang, J., Sepkovic, D.W., Trevisan, M., Berrino, F. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology, 2000, 11, 635-640.
77. Wrensch, M.R., Petrakis, N.L., King, E.B., Miike, R., Mason, L., Chew, K.L., Lee, M.M., Ernster, V. L., Hilton, J. F., Schweitzer, R. et al. Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. Am. J. Epidemiol., 1992, 135, 130-141.
78. Morimoto, Y., Conroy, S.M., Pagano, I.S., Franke, A.A., Stanczyk, F.Z., Maskarinec, G. Influence of diet on nipple aspirate fluid production and estrogen levels. Food Funct., 2011, 2, 665-670.
79. Maskarinec, G., Ollberding, N.J., Conroy, S. M., Morimoto, Y., Pagano, I.S., Franke, A.A., Gentzschein, E., Stanczyk, F.Z. Estrogen levels in nipple aspirate fluid and serum during a randomized soy trial. Cancer Epidemiol. Biomarkers Prev., 2011, 20, 1815-1821.
80. Khan, S.A., Chatterton, R.T., Michel, N., Bryk, M., Lee, O., Ivancic, D., Heinz, R., Zalles, C.M., Helenowski, I.B., Jovanovic, B.D., Franke, A.A., Bosland, M.C., Wang, J., Hansen, N.M., Bethke, K.P., Dew, A., Coomes, M., Bergan, R.C. Soy isoflavone supplementation for breast cancer risk reduction: A randomized phase II trial. Cancer Prev. Res. (Phila), 2012, 5, 309-319.
81. Petrakis, N.L., Barnes, S., King, E.B., Lowenstein, J., Wiencke, J., Lee, M.M., Miike, R., Kirk, M., Coward, L. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 1996, 5, 785-794.
82. Sartippour, M.R., Rao, J.Y., Apple, S., Wu, D., Henning, S., Wang, H., Elashoff, R., Rubio, R., Heber, D., Brooks, M.N. A pilot clinical study of short-term isoflavone supplements in breast cancer patients. Nutr. Cancer, 2004, 49, 59-65.
83. Caan, B.J., Natarajan, L., Parker, B., Gold, E.B., Thomson, C., Newman, V., Rock, C.L., Pu, M., Al-Delaimy, W., Pierce, J.P. Soy food consumption and breast cancer prognosis. Cancer Epidemiol. Biomarkers Prev., 2011, 20, 854-858.
84. Boyapati, S.M., Shu, X.O., Ruan, Z.X., Dai, Q., Cai, Q., Gao, Y.T., Zheng, W. Soyfood intake and breast cancer survival: a followup of the Shanghai Breast Cancer Study. Breast Cancer Res. Treat., 2005, 92, 11-17.
85. Fink, B.N., Steck, S.E., Wolff, M.S., Britton, J.A., Kabat, G.C., Gaudet, M.M., Abrahamson, P.E., Bell, P., Schroeder, J.C., Teitelbaum, S.L., Neugut, A.I., Gammon, M.D. Dietary flavonoid intake and breast cancer survival among women on Long Island. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 2285-2292.
86. Guha, N., Kwan, M.L., Quesenberry, C.P., Jr., Weltzien, E.K., Castillo, A.L., Caan, B.J. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: The life after cancer epidemiology study. Breast Cancer Res. Treat., 2009, 118, 395-405.
87. Wu, A.H., Pike, M.C., Williams, L.D., Spicer, D., Tseng, C.C., Churchwell, M.I., Doerge, D.R. Tamoxifen, soy, and lifestyle factors in Asian American women with breast cancer. J. Clin. Oncol., 2007, 25, 3024-3030.
88. Tempfer, C.B., Froese, G., Heinze, G., Bentz, E.K., Hefler, L.A., Huber, J.C. Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med, 2009, 122, 939-946.
89. Arjmandi, B. H., Lucas, E. A., Khalil, D. A., Devareddy, L., Smith, B. J., McDonald, J., Arquitt, A. B., Payton, M. E., Mason, C. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr. J., 2005, 4, 8.
90. Messina, M.J., Persky, V., Setchell, K.D., Barnes, S. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer, 1994, 21, 113-131.
91. Dong, J.Y., Qin, L.Q. Soy isoflavones consumption and risk of breast cancer incidence or recurrence: A meta-analysis of prospective studies. Breast Cancer Res. Treat., 2011, 125, 315-23.
92. Clarkson, T.B., Anthony, M.S., Williams, J.K., Honore, E.K., Cline, J.M. The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy. Proc. Soc. Exp. Biol. Med., 1998, 217, 365-368.
93. Hooper, L., Ryder, J.J., Kurzer, M.S., Lampe, J.W., Messina, M.J., Phipps, W.R., Cassidy, A. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: A systematic review and meta-analysis. Human Reprod. Update, 2009, 15, 423-440.
94. Arjmandi, B.H., Alekel, L., Hollis, B.W., Amin, D., Stacewicz-Sapuntzakis, M., Guo, P., Kukreja, S.C. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr, 1996, 126, 161-167.
95. Wood, C.E., Appt, S.E., Clarkson, T.B., Franke, A.A., Lees, C.J., Doerge, D.R., Cline, J.M. Effects of high-dose soy isoflavones and equol on reproductive tissues in female cynomolgus monkeys. Biol. Reprod., 2006, 75, 477-486.
96. Wood, C.E., Hester, J.M., Appt, S.E., Geisinger, K.R., Cline, J.M. Estrogen effects on epithelial proliferation and benign proliferative lesions in the postmenopausal primate mammary gland. Lab Ivest., 2008, 88, 938-948.
97. Allred, C.D., Allred, K.F., Ju, Y.H., Virant, S.M., Helferich, W.G., Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res., 2001, 61, 5045-5450.
98. Allred, C.D., Allred, K.F., Ju, Y.H., Clausen, L.M., Doerge, D.R., Schantz, S.L., Korol, D.L., Wallig, M.A., Helferich, W.G. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Carcinogenesis, 2004, 25, 211-218.
99. Rimoldi, G., Christoffel, J., Seidlova-Wuttke, D., Jarry, H., Wuttke, W. Effects of chronic genistein treatment in mammary gland, uterus, and vagina. Environ. Health Perspect., 2007, 115 Suppl 1, 62-68.
100. Yang, X., Edgerton, S.M., Kosanke, S.D., Mason, T.L., Alvarez, K.M., Liu, N., Chatterton, R.T., Liu, B., Wang, Q., Kim, A., Murthy, S., Thor, A.D. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res., 2003, 63, 2425-2433.
101. Wood, C.E., Clarkson, T B., Appt, S.E., Franke, A.A., Boue, S.M., Burow, M.E., McCoy, T., Cline, J.M. Effects of soybean glyceollins and estradiol in postmenopausal female monkeys. Nutr Cancer, 2006, 56, 74-81.
102. Wood, C.E., Register, T.C., Anthony, M.S., Kock, N.D., Cline, J.M. Breast and uterine effects of soy isoflavones and conjugated equine estrogens in postmenopausal female monkeys. J. Clin. Endocrinol. Metab., 2004, 89, 3462-3468.
103. Arjmandi, B.H., Birnbaum, R., Goyal, N.V., Getlinger, M.J., Juma, S., Alekel, L., Hasler, C.M., Drum, M. L., Hollis, B.W., Kukreja, S.C. Bone-sparing effect of soy protein in ovarian hormonedeficient rats is related to its isoflavone content. Am. J. Clin. Nutr., 1998, 68, 1364S-1368S.
104. Hooshmand, S., Khalil, D.A., Murillo, G., Singletary, K., Kamath, S.K., Arjmandi, B.H., The combination of genistin and ipriflavone prevents mammary tumorigenesis and modulates lipid profile. Clin. Nutr., 2008, 27, 643-648.
105. Gu, L., House, S.E., Prior, R.L., Fang, N., Ronis, M.J., Clarkson, T.B., Wilson, M.E., Badger, T.M., Metabolic phenotype of isoflavones differ among female rats, pigs, monkeys, and women. J. Nutr., 2006, 136, 1215-1221.
106. Setchell, K.D., Brown, N.M., Zhao, X., Lindley, S.L., Heubi, J.E., King, E.C., Messina, M.J. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am. J. Clin. Nutr., 2011, 94, 1284-1294.
107. Arjmandi, B.H., Khalil, D.A., Smith, B.J., Lucas, E.A., Juma, S., Payton, M.E., Wild, R.A. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J. Clin. Endocrinol. Metab., 2003, 88, 1048-54.